Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_assertion type Assertion NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_head.
- NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_assertion description "[Western blot analysis and quantitative reverse-transcription polymerase chain reaction (RT-PCR) revealed that cells underexpressing CCND1 exhibited decreased multidrug resistance protein 1 (MDR1) and B-cell lymphoma-2 (Bcl-2) expression, but enhanced apoptosis effector caspase-3 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_provenance.
- NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_assertion evidence source_evidence_literature NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_provenance.
- NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_assertion SIO_000772 21912938 NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_provenance.
- NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_assertion wasDerivedFrom befree-20150227 NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_provenance.
- NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_assertion wasGeneratedBy ECO_0000203 NP281214.RAnSomA1_d1PvxlbBLXnV0wYQSldi1KExbBDVYmkod29Q130_provenance.